| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the * Department of Urology, Gunma University
Graduated School of Medicine, Maebashi, Japan; and the
Department of Pharmacological Research,
Teikoku Hormone Manufacturing, Kawasaki, Japan.
| Correspondence to: Dr Bunzo Kashiwagi, Department of Urology, Gunma University Graduated School of Medicine, Showa machi, Maebashi, Gunma 371-8511, Japan (e-mail: bkashiwa{at}med.gunma-u.ac.jp). |
| Received for publication October 19, 2004; accepted for publication April 16, 2005. |
| Abstract |
|---|
|
|
|---|
Key words: LC-MS/MS, hormone, prostate, seminal vesicles
| Materials and Methods |
|---|
|
|
|---|
Experimental Method![]()
The rats were weighed and divided into 7 groups with sampling time points
of 0, 3, 6, 12, 24, 48, and 72 hours after castration (5 animals per group).
Bilateral orchiectomy was performed under pentobarbital anesthesia (50 mg/kg,
intraperitoneal injection), followed by excision of the prostate (abdominal
lobe) and seminal vesicles at the specified time point. The prostate and
seminal vesicles were weighed, frozen in liquid nitrogen, and stored at
-70°C until analysis. Blood was collected in a blood sampling tube,
clotted, and centrifuged (738 x g for 10 minutes). The
separated serum was stored at -70°C. Seminal fluid (0.5 mL) in the seminal
vesicles was collected in a test tube, and 9.5 mL of physiological saline was
added. It was then centrifuged (266 x g for 2 minutes, twice),
and the supernatant was stored at -70°C.
Chemical Products![]()
Standard T and DHT were purchased from Sigma Chemical Co (St Louis, Mo).
Tri-deuterium-labeled T (T-d3) and tri-deuterium-labeled DHT (DHT-d3) were
provided by Teikoku Hormone Mfg Co, Ltd (Kawasaki, Japan). All solvents used
were of analytical grade.
Instruments![]()
For liquid chromatography-tandem mass spectrometric analysis (LC-MS/MS),
Micromass Quattro II and HP1100 liquid chromatograph (Hewlett-Packard,
Corvallis, Ore) were connected, and a hypersil octadecylsilane (ODS) column
(internal diameter 125 x 3 mm, membrane thickness 3 µm,
Hewlett-Packard) was used.
Analytical Methods of DHT and T![]()
The prostate and seminal vesicles were completely powdered with liquid
nitrogen and transferred to 30-mL centrifuge tubes. Serum and seminal fluid
were transferred to 10-mL tubes. Internal standards of T and DHT, 1 ng each,
were added to the tubes. Steroids in the prostate and seminal vesicles were
extracted with 20 mL of 40% hexane/ethyl acetate. The organic layer was washed
sequentially with 5% sodium bicarbonate and water and dried with sodium
sulfate. Steroids were then extracted with 70% acetonitrile/water on a C18
column (washed with 6 mL of methanol and water beforehand), and the obtained
steroids were dried in a centrifugal evaporator. To increase the analytical
sensitivity, the dried steroids were reacted with 200 µL of 2%
fluoro-1-methylpyridinium-p-toluenesulfonate (Tokyo Kasei Kogyo,
Tokyo, Japan). After the reaction, the pyridinium derivatives produced were
dried under nitrogen gas and washed with 50 µL of methanol, 1 mL of
H2O, and 20 µL of 1 N HCl, and the steroid derivatives were
re-extracted on a C18 column. The steroid extract was measured by LC-MS/MS.
The HPLC conditions were: solvent, methanol/0.1%
CH3COOH-H2O 65:35; temperature 40°C; and flow rate
0.2 mL/min. For T, m/z 380.3 was activated as a precursor
ion and decomposed. Among the product ions, m/z 253 was
monitored. For DHT, m/z 382.3 was activated as a precursor
ion, and the produced m/z 255 ions were monitored. As for
the product ions of the internal standards (T-d3 and DHT-d3),
m/z 256 and m/z 258 ions were
monitored.
Preparation of Calibration Curves and Validation![]()
Validation was performed with the vehicle containing no androgen or serum
from castrated rats (Table).
Standard T (0, 15.6, 20, 62.5, 125, 500, and 1000 pg) and DHT (0. 15.6, 20,
62.5, 125, 500, and 1000 pg) were added to 7 tubes, and 1 ng of T-d3
(T-19-C2H3) and 1 ng DHT-d3
([17,16,16-2H3]-DHT) were added as the internal
standards. T and DHT were measured as described above, and the accuracy and
precision were analyzed. The accuracy was calculated by dividing the
difference between the mean analytical value and the initial amount of the
standard by the initial amount of the standard. The precision was calculated
by dividing the standard deviation by the mean analytical value. Accuracy and
precision are presented as percentages.
|
Statistical Analysis![]()
All data were analyzed with Microsoft Excel software (Microsoft Corp,
Redmond, Wash). Values were expressed as mean ± SE. Statistical
analyses for comparisons among multiple treatment groups were based on the
method of 2-way analysis of variance (ANOVA) with multiple comparisons. The
results of all statistical tests were considered significant at P
< .05.
| Results |
|---|
|
|
|---|
|
Time Course Changes in Androgen Concentration in Rat Prostate, Seminal Vesicles, Serum, and Seminal Fluid After Castration![]()
T and DHT decreased with time after castration in the prostate, seminal
vesicles, serum, and seminal fluid (Figures
2,
3,
4,
5). Seventy-two hours after
castration, T and DHT decreased to 42% and 3% of the normal levels,
respectively, in the prostate and 52% and 2%, respectively, in the seminal
vesicles. In serum, androgen concentrations were under the quantification
limits 6 hours after castration and thereafter. Three hours after castration,
T and DHT decreased to 4% and 50% of the normal levels, respectively. In
seminal fluid, T and DHT decreased to 49% and 35% of the normal levels,
respectively, 72 hours after castration.
|
|
|
|
Time Course Changes in T/DHT Ratio in Rat Prostate, Seminal Vesicles, Serum, and Seminal Fluid After Castration![]()
In the male accessory sex organs, the ratio of T in the prostate (0.06) was
lower than that in the seminal vesicles (0.13) immediately after castration (0
hours). The T/DHT ratio increased with time after castration (prostate: 3
hours, 0.06; 6 hours, 0.07; 12 hours, 0.15; 24 hours, 0.29; 48 hours, 0.65; 72
hours, 0.71; seminal vesicles: 3 hours, 0.15; 6 hours, 0.17; 12 hours, 0.2; 24
hours, 0.41; 48 hours, 1.05; 72 hours, 3.35). In serum, the T/DHT ratio was
high at 0 hours but rapidly decreased within 3 hours after castration (0
hours, 53.7; 3 hours, 4.13). In seminal fluid, no rapid change was observed in
the T/DHT ratio until 72 hours after castration and remained at about
0.5-0.8.
| Discussion |
|---|
|
|
|---|
The T and DHT levels in the male accessory organs, prostate, and seminal vesicles were compared immediately after castration. DHT was dominant in 2 organs as previously reported, and the T and DHT levels were similar to those in previous reports (Damassa and Gustafson, 1988; Hirosumi et al, 1995; Nakayama et al, 1997). The T/DHT ratio in the prostate was lower than in the seminal vesicles. Seventy-two hours after castration, T in the prostate and seminal vesicle decreased to 42% and 52% of the normal levels, respectively. These mild decreases resulted from minute amounts of T that originally existed in those tissues. However, 72 hours after castration, DHT in the prostate and seminal vesicle rapidly decreased to 3% and 2% of normal levels, respectively. Accordingly, the T/DHT ratio increased to 0.71 in the prostate 72 hours after castration and exceeded 1 in the seminal vesicles 48 hours after castration. These findings suggested that the activity of 5-alpha reductase in the prostate was higher than in the seminal vesicles (George, 1997); therefore, the T/DHT ratio of prostate was lower than that of seminal vesicles.
As for the serum T and DHT levels, T was dominant, as previously reported (Gottreich et al, 2000, Torres et al, 2003). T decreased rapidly to 4% and DHT to 50% of the normal level within 3 hours after castration. The androgen levels were under the quantification limit thereafter; thus, it was not possible to perform the measurement. These findings suggested that T in the circulation did not accumulate and was supplied by production in the testis. As for seminal fluid, the relationship between fructose in seminal fluid and serum T in castrated patients has been reported (Gonzales, 1994, 2001). There are some reports concerning T and DHT levels in human seminal fluid (Paulson et al, 1986; Zalata et al, 1995; Anderson et al, 1997). The results of our study suggested that DHT was dominant in the normal state. The T/DHT ratio in seminal fluid was higher than in the male accessory sex organs. Time course changes in the androgen levels after castration in seminal fluid were slow compared with those in the male accessory sex organs, and the T and DHT levels were still maintained at 49% and 35% of the normal levels, respectively, 72 hours after castration. In this experiment, we collected seminal fluid in the seminal vesicles. We did not measure quantity of androgen in ejaculated seminal fluid. The androgen levels in seminal fluid after castration might be affected by androgen in the seminal vesicle.
This study indicated that the highly sensitive simultaneous T and DHT measurement method established by us was capable of measuring the tissue androgen levels with the use of small amounts of specimens. The androgen levels in the male accessory sex organs and serum immediately after castration measured by our method were similar to those of current methods reported, and our method was more accurate. Our method allowed the measurement of androgen levels in the prostate during hormone therapy and in tissues with age-related decreases, which might lead to the elucidation of the causes of androgen-dependent disorders.
| References |
|---|
|
|
|---|
-reductase activity to the
reproductive tract in oligozoosermic men administered supraphysiological doses
of testosterone. J Androl. 1997; 18: 366
-371.Blaquier JA, Cameo MS, Burgos MH. The role of androgens in the maturation of epididymal spermatozoa in the guinea pig. Endocrinology. 1972; 3: 839 -842.
Damassa DA, Gustafson AW. Effects of chronic infusions of sex steroid-binding protein on the testosterone-mediated inhibition of gonadotropin secretion and maintenance of sex accessory glands in male rats. Endocrinology. 1988; 4: 1885 -1892.
Dohle GR, Smit M, Weber RF. Androgens and male fertility. World J Urol. 2003; 5: 341 -345.
George FW. Androgen metabolism in the prostate of the finasteride
treated, adult rat: a possible explanation for the differential action of
testosterone and 5
-dihydrotestosterone during development of the male
urogenital tract. Endcrinology. 1997; 3: 871
-877.
Gonzales GF. Test for androgen activity at the male reproductive tract in infertile men. Arch Androl. 1994; 3: 235 -242.
Gonzales GF. Function of seminal vesicles and their role on male fertility. Asian J Androl. 2001; 4: 251 -258.
Gottreich A, Zuri I, Barel S, Hammer I, Terkel J. Urinary testosterone levels in the male blind mole rat (Spalax ehrenbergi) affect female preference. Physiol Behav. 2000; 3: 309 -315.
Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991; 5: 1016 -1025.
Hirosumi J, Nakayama O, Chida N, Inami M, Fagan T, Sawada K, Shigematsu S, Kojo H, Notsu Y, Okuhara M. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) in vivo effects on rat and dog prostates. J Steroid Biochem Mol Biol. 1995; 4: 365 -373.
Ishigai M, Ishitani Y, Kumaki K. Characteristics of mass spectrometric analyses coupled to gas chromatography and liquid chromatography for 22-oxacalcitriol, a vitamin D3 analog, and related compounds. J Chromatogr B Biomed Sci Appl. 1997; 1-2: 11 -17.
Marcelli M, Cunningham GR. Hormonal signaling in prostatic hyperplasia and neoplasia. J Clin Endocrinol Metab. 1999; 10: 3463 -3468.
Martin J, Quirke E. Chemical derivatization for electrospray ionization mass spectrometry. 1. Alkyl halides, alcohols, phenols, thiils, and amines. Anal Chem. 1994; 8: 1302 -1315.[CrossRef]
Morioka M, Takeda K, Mitsuhata N, Ohashi T, Ohmori H. Endogenous androgen levels of human prostatic tissues. Nippon Naibunpi Gakkai Zasshi. 1982;58: 876 -885.[Medline]
Mukaiyama T, Ikeda S, Kobayashi S. A novel method for the preparation of various 2-pyridyl sulfides from alcohols. Chem Lett. 1975; 1159 -1162.
Mulligan T, Schmitt B. Testosterone for erectile failure. J Gen Intern Med. 1993; 9: 517 -521.
Nakayama O, Hirosumi J, Chida N, Takahashi S, Sawada K, Kojo H, Notsu Y. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates. Prostate. 1997; 4: 241 -249.
Orwoll ES. Osteoporosis in men. Endocrinol Metab Clin North Am. 1998;2: 349 -367.
Partin AW, Rodriguez R. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell's Urology. 8th ed. Philadelphia, Pa: Saunders; 1998.
Paulson RJ, Bernstein GS, Marrs RP, Lobo RA. Idiopathic oligospermia and peripheral androgen metabolism. Fertil Steril. 1986;46: 480 -483.[Medline]
Rassaie MJ, Kumari GL, Rao PN, Shrivastav TG, Pandey HP. Influence of different combinations of antibodies and penicillinase-labeled testosterone derivatives on sensitivity and specificity of immunoassays. Steroids. 1992;3: 112 -118.
Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, Kawabe Y, Honma S, Yamanaka H. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate. 2000; 1: 45 -55.
Taplin ME, Ho SM. Clinical review 134: the endocrinology of prostate cancer. J Clin Endocrinol Metab. 2001; 8: 3467 -3477.
Torres JM, Ruiz E, Ortega E. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status. Prostate. 2003; 1: 74 -79.
Vanderschueren D, Boonen S, Bouillon R. Osteoporosis and osteoporotic fractures in men: a clinical perspective. Baillieres Best Pract Res Clin Endocrinol Metab. 2000; 2: 299 -315.
Weinbauer G, Nieschlag E. Endocrine control of germ cell proliferation in the primate testis. What do we really know? Adv Exp Med Biol. 1997;424: 51 -58.[Medline]
Zalata A, Hafez T, Verdonck L, Vermeulen L, Comhaire F. Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract. Int J Androl. 1995; 18: 271 -277.[Medline]
This article has been cited by other articles:
![]() |
S. Shiraishi, P. W. N. Lee, A. Leung, V. H. H. Goh, R. S. Swerdloff, and C. Wang Simultaneous Measurement of Serum Testosterone and Dihydrotestosterone by Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., November 1, 2008; 54(11): 1855 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Honda, M. Hirose, K. Hara, S. Matoba, K. Inoue, H. Miki, H. Hiura, M. Kanatsu-Shinohara, Y. Kanai, T. Kono, et al. Isolation, characterization, and in vitro and in vivo differentiation of putative thecal stem cells PNAS, July 24, 2007; 104(30): 12389 - 12394. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |